Study of the Safety and Immunogenicity of H1N1 Vaccine

NCT01177202 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

H1N1 Flu

Interventions

BIOLOGICAL: HAC1 Vaccine

Sponsor

Fraunhofer, Center for Molecular Biotechnology

Collaborators

[object Object]
[object Object]